-
Despite social media buzz, Ozempic is a valuable addition to support people struggling with their weight. It has changed many of my patient’s lives for the better (remission of DM2, fatty liver disease, sleep apnea, osteoarthritic pain, depression…)
Medical Mythbusting Commentary for March 9, 2023 Source:Despite social media buzz, Ozempic is not a quick-fix weight loss solution, doctors say
-
Many established factors in the calculation of heart disease risk must be considered when interpreting the results of a study that states that the ‘keto-like’ diet may be linked to increasing that risk.
Medical Mythbusting Commentary for March 7, 2023 Source:‘Keto-like’ diet may be linked to increased risk of heart disease and higher levels of bad cholesterol, new study suggests
-
Meta-analyses of randomized controlled trials looks at efficacy of semaglutide (Ozempic) in treating people suffering with obesity
Medical Mythbusting Commentary for December 19, 2022 Source:Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)
-
Diabetes drug in short supply in U.S. (but not in Canada) after celebrities, influencers touted its weight-loss benefits.
Medical Mythbusting Commentary for December 15, 2022 Source:Diabetes drug in short supply in U.S. after celebrities, influencers touted its weight-loss benefits
-
Just a little, ok, a lot of hyperbole in this article reviewing this observational study that claims intermittent fasting can “send you to an early grave”. Once again, no causal relationship and plenty of confounding factors.
Medical Mythbusting Commentary for November 29, 2022 Source:Intermittent fasting diet could actually send you to an early grave: new study Reference:Meal Skipping and Shorter Meal Intervals Are Associated with Increased Risk of All-Cause and Cardiovascular Disease Mortality among US Adults
-
Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.
Medical Mythbusting Commentary for June 8, 2022 Source:Weight-loss drug called Wegovy receives FDA approval
-
Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.
Medical Mythbusting Commentary for May 11, 2022 Source:People Taking New Hunger-Blocking Drug Lose 24 Kilograms On Average
-
Covid-19 mortality rates up to 10 times greater in countries where overweight rates are greater than 50% of the population.
Medical Mythbusting Commentary for March 5, 2021 Source:Covid-19 death rates 10 times higher in countries where most adults are overweight, report finds
-
NEJM publishes study evaluating the use of semaglutide to assist people with weight loss. Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.
Medical Mythbusting Commentary for February 16, 2021 Reference:Last week the NEJM published a study concluding “In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.” A follow up editorial provides some perspective.